非人灵长类动物苏丹病毒感染与埃博拉病毒感染自然史比较:快速综述
该快速综述纳入24项研究(25篇文章),比较非人灵长类动物中苏丹病毒(SUDV)与埃博拉病毒(EBOV)感染的自然史。结果显示两者所致疾病高度相似,均表现为严重全身炎症反应和弥散性血管内凝血,临床病理和宿主免疫反应一致;有迹象表明EBOV病程略快、死亡率略高,但重叠明显。
要点
- 纳入24项研究(25篇文章),其中19项评估EBOV、4项评估SUDV、1项同时评估两者。
- EBOV与SUDV感染非人灵长类动物所致疾病高度相似,表现为严重全身炎症反应和弥散性血管内凝血。
- 有迹象表明EBOV病程略快、死亡率略高,但重叠明显,不同EBOV变异株间也可见微小差异。
核心结论
- EBOV与SUDV感染非人灵长类动物所致疾病高度相似,临床呈现、进展、临床病理观察和宿主免疫反应特征在两病毒间一致。
- 有迹象表明EBOV可能病程略快、死亡率略高,但重叠明显,不同EBOV变异株间也可见微小差异。
研究设计与样本
- 快速综述,共纳入24项研究(描述于25篇文章),其中19项评估EBOV、4项评估SUDV、1项同时评估两者。
- 研究比较非人灵长类动物(NHP)中EBOV与SUDV感染的自然史。
主要发现
- EBOV和SUDV感染NHP均导致严重全身炎症反应和弥散性血管内凝血,进而引起组织和器官损伤及液体丢失。
- 两病毒的临床表现与进展、临床病理观察及宿主免疫反应特征一致。
- 有迹象表明EBOV可能病程略快、死亡率略高,但重叠明显,不同EBOV变异株间也可见微小差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Uganda recently declared the end of its sixth Sudan virus (SUDV) outbreak; the prior outbreak having ended just two years earlier. Efficacious vaccines are licensed for protection against Ebola virus (EBOV), but there is no evidence that these afford clinical protection against other orthoebolaviruses. While EBOV has been extensively characterized in humans and animal models, the evidence base for SUDV is more limited due to the lower frequency of outbreaks and cases to date. It is therefore valuable to consider how, and to what extent, our knowledge and evidence base on EBOV can be leveraged to support the development of countermeasures against SUDV. This rapid review aims to examine and compare the existing evidence on the natural history of EBOV and SUDV in non-human primates (NHP). Overall, 24 studies (described in 25 articles) were identified for inclusion: 19 evaluated EBOV, four evaluated SUDV, and one evaluated both. Results confirm that EBOV and SUDV infection result in very similar disease in NHP, characterized by a severe systemic inflammatory response and disseminated intravascular coagulopathy, leading to tissue and organ damage and fluid loss. Clinical presentation and progression, clinical pathology observations, and characteristics of the host immune response were consistent across viruses. There is some indication that EBOV may result in slightly faster disease progression and marginally higher mortality than SUDV, though there is substantial overlap, and minor differences are also observed with different EBOV variants. While infection of rhesus and cynomolgus macaques with SUDV or EBOV are widely accepted models of human disease, an equivalent comparison of available human data would be valuable.
引用
- Whitworth HS, Postler TS, Cooper CL, et al. The natural history of infection with Sudan virus compared to Ebola virus in non-human primates: a rapid review. Vaccine. 2025. PMID: 40700901. doi:10.1016/j.vaccine.2025.127509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。